A recent study by our group (Moreno-Sánchez et al., 2016) showed that oxamate inhibition of cancer glycolysis was mediated by the direct moderate inhibition of several pathway sites such as LDH, PYK, and ENO. Here, PHKA2 is linked to cancer.